Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aura Biosciences, Inc.

6.26
0.0000
Post-market: 6.260.00000.00%18:14 EDT
Volume:112.56K
Turnover:707.29K
Market Cap:388.15M
PE:-3.29
High:6.42
Open:6.22
Low:6.07
Close:6.26
Loading ...
Jun 18, 2025

Major Issues Report

Form 8-K - Current report
May 16, 2025

Major Issues Report

Form 8-K - Current report
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2025

Major Issues Report

Form 8-K - Current report
May 15, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 02, 2025

Major Issues Report

Form 8-K - Current report
Mar 24, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 24, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 24, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]